| 000 | 05042cam a2200433Ii 4500 | ||
|---|---|---|---|
| 001 | 95634 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112714.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 170322t20172017sz a ob 000 0 eng d | ||
| 020 |
_a3319531565 _q(electronic bk.) |
||
| 020 |
_a9783319531564 _q(electronic bk.) |
||
| 020 |
_z3319531557 _q(hardback ; _qalk. paper) |
||
| 020 |
_z9783319531557 _q(hardback ; _qalk. paper) |
||
| 040 |
_aN$T _cN$T _dEBLCP _dMMU _dOCLCO _dN$T _dYDX _dGW5XE _dOCLCQ _dOCLCF _dOCLCO _dCOO _dAZU _dUPM _dMERER _dOCLCQ _dOCLCO _dCASUM _dVT2 _dOCLCQ _dTFH _dOCLCO _dJG0 _dOCLCO _dOCLCQ _dOCLCA _dUAB _dES-MaUEC _bspa |
||
| 050 | 4 |
_aRM275 _b.I468 2017 EB |
|
| 130 | 0 | _aImmunotherapy (Naing) | |
| 245 | 1 | 0 |
_aImmunotherapy _cAung Naing, Joud Hajjar, editors. |
| 264 | 1 |
_aCham, Switzerland _bSpringer _c[2017] |
|
| 264 | 4 | _c2017 | |
| 300 |
_a1 recurso en línea (v, 184 páginas) _bilustraciones (algunas a color) |
||
| 336 |
_astill image _bsti _2rdacontent |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 0 |
_aAdvances in experimental medicine and biology _x2214-8019 _v995 |
|
| 500 |
_aSpringerLink _bSpringer Biomedical and Life Sciences eBooks 2017 English+International |
||
| 504 | _aIncluye referencias bibliográficas | ||
| 505 | 0 | _aOverview of basic immunology for clinical investigators / Bettzy Stephen, Joud Hajjar -- Interleukin-2: old and new approaches to enhance immune-therapeutic efficacy / Pooja Dhupkar, Nancy Gordon -- Optimizing radiotherapy with immunotherapeutic approaches / Jonathan E. Schoenhals, Tijana Skrepnik, Ugur Selek, Maria A. Cortez [and others] -- Harnessing the immune system against leukemia: monoclonal antibodies and checkpoint strategies for aml / Lucia Masarova, Hagop Kantarjian, Guillermo Garcia-Mannero, Farhad Ravandi [and others] -- Immunotherapy in NSCLC: a promising and revolutionary weapon / Christian Rolfo, Christian Caglevic [and others] -- Immune therapy for sarcomas / Peter M. Anderson, Ph. D. -- Cancer imaging in immunotherapy / Yousra Eleneen, Rivka R. Colen -- Adverse events in cancer immunotherapy / Noha Abdel-Wahab, Anas Alshawa, Maria E. Suarez-Almazor -- Skin reactions to immune checkpoint inhibitors / Anisha B. Patel, Omar Pacha. | |
| 520 | 3 | _a"In the last decade, immunotherapy has revolutionized the practice of medicine in the field of oncology. This book, Immunotherapy, highlights the immunotherapeutic approaches currently in use and strategies to overcome the associated challenges. As comprehensive knowledge of basic immunology in the context of tumor biology is required to move further along the line of development in translational science, this book provides an overview of the cellular components of the immune system that interact with each other to provide a successful immune response. Immunotherapy offers promising antitumor activity across multiple cancer types as it does not attack the tumor but primarily revitalizes a suppressed immune system. It is beyond the scope of this book to discuss the immunotherapeutic approaches across the tumor board. However, the book features the role of immune-oncology in acute myeloid leukemia, non-small cell lung cancer, and sarcomas to showcase the recent advances in the management of cancer broadly classified as hematological malignancies, solid tumors, and tumors arising in the connective tissue. The book also discusses alternative formulations and combinatorial approaches to enhance the therapeutic index of these agents. As immunotherapeutic agents differ significantly from chemotherapeutic agents in response patterns and toxicity profiles, evaluating their safety and efficacy in clinical trials remains a challenge. In this book, we discuss the use of a variety of traditional and new immunotherapy criteria to evaluate response, their inadequacies, and clinical implications. The book also outlines how recent advances in medical imaging technology have the potential to provide high-dimensional data to improve decision support and individualize treatment selection and monitoring. Importantly, the book attempts to increase the awareness to immune related adverse events and the need for aggressive and judicious management of toxicities to improve treatment outcomes in patients on immunotherapy In short, this book provides a broad understanding of immunotherapy and ways to leverage the immune system to make inroads in the fight against cancer"--Publisher's description. | |
| 650 | 7 |
_aInmunoterapia _2embne _0(OCoLC)fst00968044 _0 _9145440 |
|
| 700 | 1 |
_aHajjar, Joud, _eeditor literario |
|
| 700 | 1 |
_aNaing, Aung, _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-53156-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 988 | _aEBOOK, asignarmaterias, EBSPRINGER_2017C | ||
| 998 |
_b02/2018 _dz _e- _zSI |
||
| 999 |
_c95634 _d95634 _x1 |
||